Due for re-check: the scheduled review date of 2026-09-13 has passed. Every value below still carries the source it was taken from and the passage that states it — check it against the link.
0409-4900-14 · Sodium Bicarbonate Injection · Hospira, Inc., a Pfizer Company
What is the package ndc for 0409-4900-14 · Sodium Bicarbonate Injection · Hospira, Inc., a Pfizer Company?
For 0409-4900-14 · Sodium Bicarbonate Injection · Hospira, Inc., a Pfizer Company, package ndc is 0409-4900-14; generic name is Sodium Bicarbonate Injection; manufacturer is Hospira, Inc., a Pfizer Company; status is Current; availability now is Unavailable, recorded from its source on 2026-09-01; source re-checked 2026-09-10.
"initial_posting_date": "03/01/2017", "package_ndc": "0409-4900-14", "generic_name": "Sodium Bicarbonate Injection", "related_info_link": "https://www.accessdata.fda.gov/scripts/drugshortages/dsp_ActiveIngredientDetails.cfm?AI=Sodium%20Bicarbonate%20Injection&st=d", "contact_info": "844-646-4398", "availability": "Unavailable", "related_info": "Discontinuation of the manufacture of the drug"
— api.fda.gov, retrieved 2026-09-01
- Package NDC
- 0409-4900-14 verified
- Generic name
- Sodium Bicarbonate Injection verified
- Manufacturer
- Hospira, Inc., a Pfizer Company verified
- Status
- Current verified
- Availability now
- Unavailable verified
- FDA note
- Discontinuation of the manufacture of the drug verified
- Initial posting date
- 03/01/2017 verified
- Last update date
- 08/24/2026 verified
- Days in shortage
- 3471 our reading
- Reason for shortage
- Discontinuation of the manufacture of the drug verified
- Dosage form
- Injection verified
- Therapeutic category
- Endocrinology/Metabolism verified
Values marked our reading are our classification of what the source says — the source does not print them in those words. The quote below is the evidence for each one; judge it yourself.
Where each value comes from
The values above are stated away from the sentence quoted with the answer, so the passage that states them is shown here too.
Manufacturer, Status, Last update date, Reason for shortage, Dosage form and Therapeutic category
"update_date": "08/24/2026", "therapeutic_category": [ "Endocrinology/Metabolism", "Gastroenterology", "Pediatric" ], "dosage_form": "Injection", "presentation": "Sodium Bicarbonate, Injection, 10 mEq/10 mL (8.4%, 1 mEq/mL) Syringes (NDC 0409-4900-14)", "company_name": "Hospira, Inc., a Pfizer Company", "shortage_reason": "Discontinuation of the manufacture of the drug", "status": "Current"
— all from api.fda.gov, retrieved 2026-09-01
Source
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hospira,%20Inc.,%20a%20Pfizer%20Company%22+AND+generic_name%3A%22Sodium%20Bicarbonate%20Injection%22+AND+status%3A%22Current%22&limit=1000